Primary Systemic Amyloidosis (AL)
Also known as: Primary Systemic (AL) Amyloidosis / Primary Systemic Amyloidosis / Primary Amyloidosis of Light Chain Type / Amyloid Light Chain (AL) Amyloidosis / Primary Amyloidosis / AL Amyloidosis / Light Chain (AL) Amyloidosis / Light-Chain Amyloidosis / Systemic Light Chain Disease / Amyloid light-chain amyloidosis / Immunoglobulin Light-chain Amyloidosis / Amyloid light-chain amyloidosis (disorder) / Immunoglobulin deposition disease (morphologic abnormality)
Drug | Drug Name | Drug Description |
---|---|---|
DB09331 | Daratumumab | A CD38-directed cytolytic antibody used alone or as an adjunct drug in the treatment of multiple myeloma and light chain amyloidosis. |
DB00480 | Lenalidomide | A thalidomide derivative used to treat multiple myeloma and anemia in low to intermediate risk myelodysplastic syndrome. |
DB01041 | Thalidomide | A medication used to treat cancers, particularly newly diagnosed multiple myeloma, and erythema nodosum leprosum. |